Monoclonal antibodies targeting the programmed cell death 1 (PD-1) receptor and its ligand (PD-L1) have been showing promising results in advanced non-small cell lung cancer (NSCLC). Here, we investigated PD-L1 messenger RNA (mRNA) expression by a novel RNA in situ hybridization technique and compared it with PD-L1 protein expression in NSCLC.